Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L DuPont

Showing results (81-90 of 829) with videos related to

Pageof 83
Sort By:
The Journal of Infection|January 26, 2005
Rifaximin--a novel antimicrobial for enteric infectionsDavid B Huang, Herbert L DuPont
Expert Review of Anti-Infective Therapy|June 15, 2006
Current and future developments in travelers' diarrhea therapyHoonmo L Koo, Herbert L DuPont
Chemotherapy|April 28, 2005
Rifaximin: in vitro and in vivo antibacterial activity--a reviewZ D Jiang, H L DuPont
The Lancet. Infectious Diseases|May 28, 2005
Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infectionDavid B Huang, Herbert L DuPont
Journal of Addictive Diseases|March 17, 2009
Comorbidity and "self-medication"Robert L DuPont, Mark S Gold
Reviews of Infectious Diseases|May 1, 1987
Use of antimicrobial agents in animal feeds: implications for human healthH L DuPont, J H Steele
Journal of Clinical Microbiology|April 1, 1979
Pooling method for screening large numbers of Escherichia coli for production of heat-stable enterotoxin, and its application in field studiesP A Byers, H L DuPont
Annual Review of Marine Science|February 19, 2011
Microbial metagenomics: beyond the genomeJack A Gilbert, Christopher L Dupont
Alimentary Pharmacology & Therapeutics|March 22, 2007
Review article: the history of acute infectious diarrhoea management--from poorly focused empiricism to fluid therapy and modern pharmacotherapyZ H McMahan, H L DuPont
The Journal of Infection|September 11, 2007
Advances in defining etiology and new therapeutic approaches in acute diarrheaLuis A Marcos, Herbert L DuPont
Pageof 83

Showing results (81-90 of 829) with videos related to

Sort By:
Pageof 83
The Journal of Infection|January 26, 2005
Rifaximin--a novel antimicrobial for enteric infectionsDavid B Huang, Herbert L DuPont
Expert Review of Anti-Infective Therapy|June 15, 2006
Current and future developments in travelers' diarrhea therapyHoonmo L Koo, Herbert L DuPont
Chemotherapy|April 28, 2005
Rifaximin: in vitro and in vivo antibacterial activity--a reviewZ D Jiang, H L DuPont
The Lancet. Infectious Diseases|May 28, 2005
Problem pathogens: extra-intestinal complications of Salmonella enterica serotype Typhi infectionDavid B Huang, Herbert L DuPont
Journal of Addictive Diseases|March 17, 2009
Comorbidity and "self-medication"Robert L DuPont, Mark S Gold
Reviews of Infectious Diseases|May 1, 1987
Use of antimicrobial agents in animal feeds: implications for human healthH L DuPont, J H Steele
Journal of Clinical Microbiology|April 1, 1979
Pooling method for screening large numbers of Escherichia coli for production of heat-stable enterotoxin, and its application in field studiesP A Byers, H L DuPont
Annual Review of Marine Science|February 19, 2011
Microbial metagenomics: beyond the genomeJack A Gilbert, Christopher L Dupont
Alimentary Pharmacology & Therapeutics|March 22, 2007
Review article: the history of acute infectious diarrhoea management--from poorly focused empiricism to fluid therapy and modern pharmacotherapyZ H McMahan, H L DuPont
The Journal of Infection|September 11, 2007
Advances in defining etiology and new therapeutic approaches in acute diarrheaLuis A Marcos, Herbert L DuPont
Pageof 83